Loading…
Hosted by ZS · 🇺🇸 US · EN-US · 33 episodes
Established thought leaders with verified media credentials.
Transforming Biopharma by ZS dissects the complex world of pharmaceuticals through candid conversations. Hosted by Maria Whitman, Transforming Biopharma by ZS covers a variety of perspectives from industry leaders who are pushing boundaries and redesigning the future.
ZS hosts Transforming Biopharma, a science show with 33 episodes published.
Companies are making meaningful progress in bringing barriers-driven engagement™ to life—embedding orchestration into workflows and rethinking how CRM supports smarter decision-making, coordination and customer progress.
The rapid evolution of generative AI has led to increased adoption but also raises significant compliance challenges. ZS Principal Michael Shaw joins the podcast to discuss the importance of responsible and ethical AI ad
As senior vice president of customer distribution experience at McKesson, Ammie McAsey makes it a point to connect her day-to-day work with the company’s mission of improving healthcare in every setting. Learn how she’s
Colin Lake, VP and head of digital care transformation, neurology and rare disease at UCB, is passionate about helping patients with rare diseases. He joins Maria Whitman to talk about how UCB has focused on simplifying
How should pharma companies respond to the current “hinge moment” where new technologies are enabling breakthroughs in drug discovery, manufacturing and customer engagement? Maria Whitman’s guest Alex Koehler, vice presi
The opportunities to reshape customer engagement have never been greater for pharma, but what role does the customer relationship management (CRM) system play? Kyrsten Musich, vice president of healthcare and life scienc
Drive behavior-changing personalized customer engagement at scale by addressing customer barriers with a powerful customer relationship management (CRM) system. ZS experts Omer Hancer, Namita Powers and Srihari Sarangan
Joe DePinto, McKesson’s head of cell and gene advanced therapies, supports patients, providers and payers throughout the treatment journey. He’s particularly passionate about helping patients get access to groundbreaking
If we want to make change in healthcare, we can’t take a one-dimensional approach. We need a multifaceted plan. Having just celebrated its 100th anniversary, the American Heart Association (AHA) is pursuing that vision.
Clinical trial sites are important players in biopharma’s success. In this episode, we hear from site experts Lauren Wall of the University of Chicago and Caroline Smith of Charter Research on how pharma can forge succes
What’s the role of culture in an organization and how can it play a pivotal role in shaping performance or even helping businesses transform? Maria Whitman sits down with Paul Ingram, professor of business at Columbia Un
Maria Whitman interviews Mike Tushman, professor at Harvard Business School, about the importance of organizational architecture during times of transformation. He describes how companies that successfully transform crea
How can healthcare and biopharma meet patients where they are? Maria Whitman interviews Oya Gilbert, a podcaster and patient advocate, about his journey as a multiple myeloma patient. They also talk about Oya’s work with
How can pharma use AI and other technology to deliver a better customer experience? Maria Whitman and a panel of ZS experts discuss pharma’s next-generation commercial model. Carolyn Morrow, Namita Powers, Srihari Sarang
Recent headlines about the use of prescription drugs for weight loss make obesity a prominent and relevant topic in today’s discussions about health and well-being. Bill Coyle, ZS’s global head of biopharma, and Mandi Wh
Yelak Biru, president and CEO of the International Myeloma Foundation, is passionate about patient advocacy with good reason—he’s been one himself for 28 years. Yelak joins Maria Whitman to talk about his patient experie
As biopharma transforms its commercial model, what can it learn from other industries? To find out, Maria Whitman sits down with Arun Shastri, global AI practice lead at ZS. Arun’s an expert on how organizations are mode
Madhavi Ramakrishna, global vice president and chief digital officer of commercial, GSK, is passionate about data and technology. A former executive in broadcast media, she’s now at the forefront of adopting analytics to
Savitri Basavaiah, vice president portfolio and commercialization strategy at Janssen, the Pharmaceutical Companies of Johnson & Johnson, has a deep background in biopharma. She joins Maria Whitman to talk about the broa
Propeller Health brings digital therapeutic expertise together with respiratory care experience to create solutions that improve patients’ lives. General Manager Susa Monacelli joins Maria Whitman to give her perspective
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Transforming Biopharma has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their science audience.
Transforming Biopharma is hosted by ZS. The show is categorised under science (life) and has published 33 episodes.
Transforming Biopharma has published 33 episodes.
Transforming Biopharma regularly covers science, life. It sits in the science category, with a life focus.
Transforming Biopharma is accessible for guests with genuine science expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
Transforming Biopharma hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of Transforming Biopharma average 43 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates Transforming Biopharma's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 2 days ago.